Experiment summary for ENCSR895JMI
doi:10.17989/ENCSR895JMI
Summary
- Status
- released
- Assay
- ChIP-seq (TF ChIP-seq)
- Target
- RAD21
- Biosample summary
- Homo sapiens A549 treated with 100 nM dexamethasone (agonist) for 0.5 hours
- Biosample Type
- cell line
- Replication type
- isogenic
- Description
- RAD21 ChIP-seq on A549 cell line treated with 100 nM dexamethasone for 0.5 hours.
- Treatments
- 100 nM dexamethasone (CHEBI:41879) for 0.5 hours
- Nucleic acid type
- DNA
- Library starting quantity
- 7ng
- Size range
- >200
- Fragmentation methods
- sonication (Bioruptor Twin)
- Size selection method
- dual SPRI
- Platform
- Illumina HiSeq 2500, Illumina HiSeq 4000
- Controls
Attribution
Genomics of Gene Regulation Project
- Lab
- Tim Reddy, Duke
- Award
- U01HG007900 (Tim Reddy, Duke)
- Project
- GGR
- External resources
- Aliases
- tim-reddy:A549.RAD21.dex.00h30m
- Date submitted
- March 6, 2018
- Date released
- March 15, 2018
- Treatment Time Series
- ENCSR501UJL
- Annotation (gkmsvm-model)
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Antibody | Library |
---|---|---|---|---|---|
2 | 1 | Homo sapiens A549 cell line treated with 100 nM dexamethasone (agonist) for 0.5 hours | ENCBS274ZVG | ENCAB695QDA | ENCLB779KYC |
1 | 1 | Homo sapiens A549 cell line treated with 100 nM dexamethasone (agonist) for 0.5 hours | ENCBS108SYG | ENCAB695QDA | ENCLB704PDV |
3 | 1 | Homo sapiens A549 cell line treated with 100 nM dexamethasone (agonist) for 0.5 hours | ENCBS539ECE | ENCAB695QDA | ENCLB637TQB |